Medications for Venous Thrombosis

39 results

  • Apixaban (apixaban)

    (Apixaban)
    Macleods Pharmaceuticals Limited
    Usage: Apixaban is indicated for reducing stroke and systemic embolism risk in nonvalvular atrial fibrillation, prophylaxis of deep vein thrombosis following hip or knee surgery, and treatment of deep vein thrombosis and pulmonary embolism. It also reduces the risk of recurrent DVT and pulmonary embolism after initial therapy.

  • Ceprotin (protein c concentrate human)

    (Protein C Concentrate Human)
    Takeda Pharmaceuticals America, Inc.
    Usage: CEPROTIN® is indicated for the prevention and treatment of venous thrombosis and purpura fulminans in neonates, pediatric, and adult patients with severe congenital Protein C deficiency.

  • Dabigatran etexilate (dabigatran etexilate)

    (dabigatran etexilate)
    Apotex Corp.
    Usage: Dabigatran etexilate capsules are indicated for reducing the risk of stroke and systemic embolism in non-valvular atrial fibrillation, treating deep venous thrombosis and pulmonary embolism, preventing their recurrence, and prophylaxis following hip replacement surgery in adult patients.

  • Dabigatran etexilate (dabigatran etexilate)

    (Dabigatran Etexilate)
    Mylan Pharmaceuticals Inc.
    Usage: Dabigatran etexilate capsules are indicated for reducing the risk of stroke and systemic embolism in non-valvular atrial fibrillation, treating and preventing deep vein thrombosis and pulmonary embolism in adults and pediatric patients aged 8-17, and preventing recurrence of venous thromboembolic events.

  • Dabigatran etexilate (dabigatran etexilate)

    (Dabigatran etexilate)
    Dr. Reddy's Laboratories Inc.
    Usage: Dabigatran etexilate capsules are indicated for reducing stroke risk in non-valvular atrial fibrillation, treating deep venous thrombosis and pulmonary embolism, providing prophylaxis following hip replacement surgery, and treating and preventing venous thromboembolic events in pediatric patients aged 8 to under 18 years.

  • Dabigatran etexilate (dabigatran etexilate)

    (Dabigatran Etexilate)
    Alembic Pharmaceuticals Limited
    Usage: Dabigatran etexilate is indicated for reducing the risk of stroke and systemic embolism in non-valvular atrial fibrillation, treating deep venous thrombosis and pulmonary embolism, preventing recurrence of these conditions, and prophylaxis following hip replacement surgery in adults.

  • Enoxaparin sodium (enoxaparin sodium)

    (Enoxaparin Sodium)
    Fresenius Kabi USA, LLC
    Usage: Enoxaparin sodium injection is indicated for the prophylaxis and treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), as well as for the prevention of ischemic complications in unstable angina and non-Q-wave myocardial infarction. Additionally, it aids in treating acute ST-segment elevation myocardial infarction.

  • Enoxaparin sodium (enoxaparin sodium)

    (Enoxaparin sodium)
    BluePoint Laboratories
    Usage: Enoxaparin Sodium Injection is indicated for the prophylaxis of deep vein thrombosis (DVT) in surgical and medical patients, treatment of acute DVT with warfarin, prophylaxis of ischemic complications in unstable angina and myocardial infarction, and treatment of acute ST-segment elevation myocardial infarction (STEMI) with aspirin.

  • Enoxaparin sodium (enoxaparin sodium)

    (enoxaparin sodium)
    Apotex Corp.
    Usage: Enoxaparin sodium is indicated for: prophylaxis of deep vein thrombosis (DVT) in surgical and medical patients; inpatient/outpatient treatment of acute DVT with/without pulmonary embolism; prophylaxis of ischemic complications in unstable angina and non-Q-wave myocardial infarction; and treatment of acute ST-segment elevation myocardial infarction (STEMI) with aspirin.

  • Enoxaparin sodium (enoxaparin sodium)

    (enoxaparin sodium)
    Fresenius Kabi USA, LLC
    Usage: Enoxaparin sodium is indicated for the prophylaxis of deep vein thrombosis (DVT) in at-risk patients, treatment of acute DVT with or without pulmonary embolism, prophylaxis of ischemic complications in unstable angina, and treatment of acute ST-segment elevation myocardial infarction (STEMI) alongside aspirin.